Benzinga | Feb 23, 2021 03:57PM EST

Pieris Pharmaceuticals Granted U.S. Patent Titled 'Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response'

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=2&f=G&l=50&d=PTXT&p=1&S1=pieris&OS=pieris&RS=pieris